The results of the Breathe Easy study were published years ago. Given the track record of Udantha and associates of getting studies published in journals, I'm not sure how any research that doesn't bring drastic new information to the table (eg Covid-trial results) is part of continuous disclosure.
The fact that this study was published isn't bad, it's a good thing for increased exposure. The fact that they chose to announce it through an ASX release, especially after a string of other announcements, though does make my mind wander a little cynical.
- Forums
- ASX - By Stock
- RAP
- Ann: Publication on challenges of diagnosing respiratory disease
Ann: Publication on challenges of diagnosing respiratory disease, page-20
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)